- FAQs – On DPCO: Drugs (Prices Control) Order, 2013 - April 20, 2021
- FAQs – on Blood Pressure Monitoring Devices - March 23, 2021
- FAQs – on Alcohol(in Pharma Industry) - March 19, 2021
Last Updated on July 18, 2021 by The Health Master
FAQs – On Narcotic Drugs, Brand Names of drug (G.S.R. no. 828 (E) dated 06.11.2019) etc.
Q1: Who issues permission for manufacturing of Narcotic drugs?
Ans: Excise and Taxation department issues permission on Form 24 to the manufacturer on the recommendation of State Drugs Controller.
Q2: Who issues permission for sale to the chemist shops for sale of Narcotic drugs?
Ans: Excise and Taxation department issues permission on Form 25 to the chemist shop on the recommendation of State Drugs Controller.
Q3: Whether the nursing homes required license for stocking Narcotic drugs?
Ans: Yes, RMI (Registered Medical Institute) certificate issued by State Drugs Controller in which six drugs has been notified which come under this certificate.
Also read More FAQs, click here
Q4: What are the new guidelines regarding Brand Name permissions to the manufacture for allopathic drugs?
Ans: As per Govt. notification no. 828(E) dated 06.11.2019, the allopathic drug manufacturer if wants to manufacture drugs by brand name then he should submit Form-51 to the concerned State Drug Controller.
To download the notification, click here
Q5: Is any fee / challan form required for taking permission?
Ans: No. If the firm is already having permission of the drug in generic then there is no need of extra fee.
Q6: What is the status of Tramadol salt?
Ans: This drug comes under NDPS Act as psychotropic substances on dated 26.04.2018.
Q7: What is status of combination of Buprenorphine+Naloxone sublingual tablets?
Ans: These tablets are covered under NDPS Act, official in USP 2018. This preparation can be supplied to psychiatric clinics and hospitals in addition to de-addiction centres as per latest DCG(I)’s letter dated 28.03.2019.
To read all FAQs of the author, click here